Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Revenue

Compare
379 Followers

Day One Biopharmaceuticals Revenue

Day One Biopharmaceuticals had a revenue of 39.80M in the quarter ending Sep 30, 2025, with 17.36%. This bring the company's revenue in the last twelve months to 133.67M, Increased -28.76%. In the fiscal year ending Dec 31, 2024, Day One Biopharmaceuticals had annual revenue of 131.16M with Infinity% growth.
Revenue (ttm)
133.67M
Revenue Growth
31.11%
P/S Ratio
8.09
Revenue/Employee
$724,646
Employees
181
Market Cap
$1.06B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
131.16M-13,116,100,000.00%
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis